title: Allo- and xeno-reassembly of human and rat myometrium from cells and scaffolds.
abstract: Neo-myometrium was created by culturing isolated myocytes into decellularized rat and human myometrial scaffolds. The dual purpose of the uterus is to accommodate the growing fetus, and then expel the fetus at term by phasically contracting it. The first function requires physical robustness as well as the ability to expand and remodel. Congenital anomalies or previous surgeries can mechanically compromise the uterus and lead to major complications in pregnancy. The second function utilizes multiple interactions of complex physiological mechanisms that have yet to be fully elucidated, and this knowledge gap contributes to the continuation of serious complications of pregnancy. To address both problems, we reconstructed myometrium from isolated myocytes and scaffold. From both rat and human myometrium, myocytes were isolated using collagenase digestion, and scaffolds were isolated using ethanol/ trypsin protocols. The number of myocytes was amplified using monolayer culture, and then, the myocytes were cultured back into the scaffolds. We called this engineered tissue neo-myometrium, with allo-neo-myometrium being made from components of the same species, and xeno-neo-myometrium from across species. By artificially creating defects in rat scaffold, allo-neo-myometrium was created that demonstrated rapid scaffold remodeling. Xeno-neo myometrium (human myocytes/rat scaffold) was created and demonstrated myocytes occurring in bundles 500 μm deep in the scaffold. These experiments provide proof of principle that modest numbers of myocytes can be amplified and used to create a larger volume of engineered tissue, which may be useful for semi-autologous transplantation to repair structural defects of the human uterus. In isometric contractility experiments, coordinated contractions were observed in xeno-neo-myometrium (human myocytes, rat scaffold), but not allo-neo-myometrium (human myocytes, human scaffold).
authors.affiliation: Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT 05401, USA. youngschwarzenberger@gmail.com
authors.forename: Roger C
authors.initials: RC
authors.lastname: Young
authors.forename: Gabriela
authors.initials: G
authors.lastname: Goloman
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D032342:Muscle Cells / Q000166:cytology; D009215:Myometrium / Q000166:cytology*; D011247:Pregnancy; D051381:Rats; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
references.citation: Eur J Obstet Gynecol Reprod Biol. 2009 May;144 Suppl 1:S40-4
references.pmid: 19303192
references.citation: Best Pract Res Clin Obstet Gynaecol. 2002 Feb;16(1):69-79
references.pmid: 11866498
references.citation: Reprod Sci. 2009 Aug;16(8):734-9
references.pmid: 19380901
references.citation: J Tissue Eng Regen Med. 2008 Jan;2(1):50-60
references.pmid: 18361481
references.citation: Arch Gynecol Obstet. 2011 Apr;283(4):723-7
references.pmid: 20352237
references.citation: J Atheroscler Thromb. 2010 Jul 30;17(7):675-87
references.pmid: 20523011
references.citation: Tissue Eng. 2003 Jun;9(3):451-9
references.pmid: 12857413
references.citation: J Biomed Mater Res A. 2004 Aug 1;70(2):224-34
references.pmid: 15227667
references.citation: Ann N Y Acad Sci. 2007 Apr;1101:72-84
references.pmid: 17442780
references.citation: Hum Reprod Update. 2010 Nov-Dec;16(6):725-44
references.pmid: 20551073
references.citation: J Appl Physiol (1985). 2005 Jun;98(6):2321-7
references.pmid: 15894540
references.citation: Am J Obstet Gynecol. 2002 Mar;186(3):504-11
references.pmid: 11904615
references.citation: Int J Artif Organs. 2008 Jan;31(1):62-7
references.pmid: 18286456
references.citation: Am J Perinatol. 2012 Jun;29(6):465-71
references.pmid: 22399223
references.citation: Expert Opin Pharmacother. 2008 May;9(7):1153-68
references.pmid: 18422473
references.citation: Tissue Eng Part A. 2009 Jul;15(7):1611-8
references.pmid: 19061433